Risperidone tablets, used to treat schizophrenia and bipolar disorder, are the generic version of Janssen’s Risperdal tablets. Mylan will ship the product shortly.
Currently, the company has 109 abbreviated new drug applications pending FDA approval, 22 of which are potential first-to-file opportunities.